SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The Total revenue for the quarter ended December 2022 of  Rs. 3947.50 millions grew by 293.41% from Rs. 1003.40 millions.The Total Profit for the quarter ended December 2022 of Rs. 4.20 millions grew from Rs.-1395.70 millions Operating profit Margin for the quarter ended December 2022 improved to 520.60% as compared to -918.60% of corresponding quarter ended December 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 3947.50 1003.40 293.41 10631.90 9075.20 17.15 12683.40 16168.80 -21.56
Other Income 67.70 47.60 42.23 170.20 140.70 20.97 187.60 284.10 -33.97
PBIDT 520.60 -918.60 -156.67 995.10 814.80 22.13 991.10 4137.40 -76.05
Interest 236.40 178.20 32.66 681.00 538.10 26.56 752.70 844.70 -10.89
PBDT 284.20 -1112.00 -125.56 314.10 254.90 23.22 203.50 3292.70 -93.82
Depreciation 278.90 283.70 -1.69 845.00 842.70 0.27 1120.10 1083.10 3.42
PBT 5.30 -1395.70 -100.38 -530.90 -587.80 -9.68 -916.60 2209.60 -141.48
TAX 1.10 0.00 0.00 -244.20 0.00 0.00 -331.00 0.00 0.00
Deferred Tax 2.20 147.70 -98.51 -243.10 0.00 0.00 -331.00 -386.40 -14.34
PAT 4.20 -1395.70 -100.30 -286.70 -587.80 -51.22 -585.60 2209.60 -126.50
Equity 360.00 359.50 0.14 360.00 359.50 0.14 360.00 359.30 0.19
PBIDTM(%) 13.19 -91.55 -114.41 9.36 8.98 4.25 7.81 25.59 -69.46

Solara Active Pharma Share Price

499.25 9.95 (2.03%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×